Management of Occupational and Nonoccupational HIV Exposure

  • Author: Christopher B. Hurt, MD (More Info)
  • Editors In Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 8/1/18 (What's New)

Summary

  • Cost-effectiveness of PEP programs can be optimized by attempting to target prophylaxis to only individuals with high-risk exposures[Pinkerton 2004a]
  • Private insurance may pay for prophylactic antiretroviral agents, but state Medicaid programs often decline to provide antiretroviral agents for persons who are HIV uninfected[Landovitz 2009]
    • Local organizations have assumed challenge of developing nontraditional methods for funding PEP for uninsured and Medicaid patients[Landovitz 2009]

Action required